131 related articles for article (PubMed ID: 7015475)
1. The association between plasma GIP and insulin after oral glucose.
Lauritsen KB; Moody AJ
Scand J Gastroenterol; 1980; 15(8):953-7. PubMed ID: 7015475
[TBL] [Abstract][Full Text] [Related]
2. Gastric inhibitory polypeptide (GIP) and insulin release in response to oral and intravenous glucose in uremic patients.
Lauritzen JB; Lauritsen KB; Olsen ME; Timmerman I
Metabolism; 1982 Nov; 31(11):1096-9. PubMed ID: 6752641
[TBL] [Abstract][Full Text] [Related]
3. The response of gastric inhibitory polypeptide (GIP) and insulin to glucose in duodenal ulcer patients.
Lauritsen KB; Moody AJ
Diabetologia; 1978 Mar; 14(3):149-53. PubMed ID: 658630
[TBL] [Abstract][Full Text] [Related]
4. Gastric inhibitory polypeptide (GIP) and insulin release after small-bowel resection in man.
Lauritsen KB; Moody AJ; Christensen KC; Lindkaer Jensen S
Scand J Gastroenterol; 1980; 15(7):833-40. PubMed ID: 7010526
[TBL] [Abstract][Full Text] [Related]
5. Glucose-induced GIP levels in patients with insulinoma.
Tamburrano G; Lala A; Mauceri M; Leonetti F; Andreani D
Horm Metab Res; 1984 Dec; 16 Suppl 1():200-3. PubMed ID: 6099816
[TBL] [Abstract][Full Text] [Related]
6. Gastric inhibitory polypeptide and insulin: response to intraduodenal and intravenous glucose infusions in fetal and neonatal pigs.
Kühl C; Hornnes PJ; Jensen SL; Lauritsen KB
Endocrinology; 1980 Nov; 107(5):1446-50. PubMed ID: 7000494
[TBL] [Abstract][Full Text] [Related]
7. The effect of jejunoileal bypass on postprandial release of plasma gastric inhibitory polypeptide (GIP).
Jorde R; Burhol PG; Johnson JA
Scand J Gastroenterol; 1981; 16(2):313-9. PubMed ID: 7031848
[TBL] [Abstract][Full Text] [Related]
8. Gastric inhibitory polypeptide (GIP) response to an oral glucose load in the patients with diabetes mellitus.
Nakanome C; Akai H; Umezu M; Toyota T; Goto Y
Tohoku J Exp Med; 1983 Mar; 139(3):287-92. PubMed ID: 6344327
[TBL] [Abstract][Full Text] [Related]
9. The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man.
Falko JM; Crockett SE; Cataland S; O'Dorisio TM; Kramer W; Mazzaferri EL
Clin Endocrinol (Oxf); 1980 Dec; 13(6):587-93. PubMed ID: 7014042
[TBL] [Abstract][Full Text] [Related]
10. Gastric inhibitory polypeptide and insulin release in response to oral and intravenous glucose in coeliac disease.
Lauritsen KB; Lauritzen JB; Christensen KC
Scand J Gastroenterol; 1982 Mar; 17(2):241-5. PubMed ID: 6753103
[TBL] [Abstract][Full Text] [Related]
11. Failure of fasting to influence the GIP response to oral glucose in non-obese human subjects.
Andrews WJ; Henry RW; Alam MJ; Alberti KG; Buchanan KD
Diabetologia; 1983 Oct; 25(4):372-4. PubMed ID: 6357919
[TBL] [Abstract][Full Text] [Related]
12. The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus.
Elahi D; Andersen DK; Muller DC; Tobin JD; Brown JC; Andres R
Diabetes; 1984 Oct; 33(10):950-7. PubMed ID: 6383904
[TBL] [Abstract][Full Text] [Related]
13. Gastric inhibitory polypeptide (GIP) release and incretin effect after oral glucose in obesity and after jejunoileal bypass.
Lauritsen KB; Christensen KC; Stokholm KH
Scand J Gastroenterol; 1980; 15(4):489-95. PubMed ID: 7001614
[TBL] [Abstract][Full Text] [Related]
14. Gastric inhibitory polypeptide (GIP) in maturity-onset diabetes mellitus.
Crockett SE; Mazzaferri EL; Cataland S
Diabetes; 1976 Oct; 25(10):931-5. PubMed ID: 976601
[TBL] [Abstract][Full Text] [Related]
15. Diurnal GIP, PP and insulin levels in morbid obesity before and after stapled gastric partitioning with gastro-gastrostomy.
Amland PF; Jorde R; Giercksky KE; Burhol PG
Int J Obes; 1984; 8(2):117-22. PubMed ID: 6373640
[TBL] [Abstract][Full Text] [Related]
16. Effects of physical training on insulin, connecting peptide (C-peptide), gastric inhibitory polypeptide (GIP) and pancreatic polypeptide (PP) levels in obese subjects.
Krotkiewski M; Björntorp P; Holm G; Marks V; Morgan L; Smith U; Feurle GE
Int J Obes; 1984; 8(3):193-9. PubMed ID: 6378815
[TBL] [Abstract][Full Text] [Related]
17. Enteroglucagon and GIP after oral glucose in patients with prolactinoma and acromegaly.
Cassar J; Ghatei MA; Sarson DL; Joplin GF; Mashiter K; Bloom SR
Clin Endocrinol (Oxf); 1983 Jan; 18(1):95-102. PubMed ID: 6342859
[TBL] [Abstract][Full Text] [Related]
18. Serum gastric inhibitory polypeptide (GIP) in duodenal ulcer disease: relationship to glucose tolerance, insulin, and gastrin release.
Arnold R; Creutzfeldt W; Ebert R; Becker HD; Börger HW; Schafmayer A
Scand J Gastroenterol; 1978; 13(1):41-7. PubMed ID: 635445
[TBL] [Abstract][Full Text] [Related]
19. Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese men.
Matikainen N; Söderlund S; Björnson E; Bogl LH; Pietiläinen KH; Hakkarainen A; Lundbom N; Eliasson B; Räsänen SM; Rivellese A; Patti L; Prinster A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR
Nutr Metab Cardiovasc Dis; 2017 Jun; 27(6):534-542. PubMed ID: 28428027
[TBL] [Abstract][Full Text] [Related]
20. Different response of gastric inhibitory polypeptide to glucose and fat from duodenum and jejunum.
Schattenmann G; Ebert R; Siewert R; Creutzfeldt W
Scand J Gastroenterol; 1984 Mar; 19(2):260-6. PubMed ID: 6372074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
